Matteo Fassan

Liver steatosis in children with chronic hepatitis C.

Micro-RNA profiling in kidney and bladder cancers.

Primary squamous cell carcinoma of the thyroid: immunohistochemical profile and literature review.

Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients.

Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.

An antimetastatic role for decorin in breast cancer.

Micronuclei and broken eggs in human liver carcinogenesis.

18F-FDG PET findings and GLUT-1 expression in IPMNs of the pancreas.

The role of Helicobacter pylori in the spectrum of Barrett's carcinogenesis.

Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth.

Proepithelin is an autocrine growth factor for bladder cancer.

Pancreatic endocrine tumor in multiple endocrine neoplasia type 1 syndrome with intraductal growth into the main pancreatic duct.

Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor.

Diffuse leptomeningeal glioneuronal tumors: a new entity?

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.

Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia.

CDX2 hox gene product in a rat model of esophageal cancer.

MicroRNA expression profiling of male breast cancer.

Targeted therapies in the management of metastatic bladder cancer.

Neck emergency due to parathyroid adenoma bleeding: a case report.

Radiological-pathological comparison in a case of conjoined gnatho-thoracopagus twins.

The original sin of oesophageal mucosa.

Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma.

Somatostatin receptor type 2 (SSTR2) in bronchopulmonary carcinoids.

Programmed cell death 4 protein in esophageal cancer.

Aurora kinase A in Barrett's carcinogenesis.

Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis.

Microsatellite instability and hMLH1 and hMSH2 expression in renal tumors.

Concurrent pheochromocytoma and cortical carcinoma of the adrenal gland.

MGMT promoter methylation in pediatric high-grade gliomas.

MicroRNA expression profiling in human Barrett's carcinogenesis.

PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis.

The war of the worlds: metaplastic versus nonmetaplastic atrophic gastritis.

HER-2/neu expression is consistent in primary and metastatic lung adenocarcinoma.

Helicobacter pylori Infection, Intestinal Metaplasia, and Gastric Cancer Risk in Eastern Siberia.

Gastritis: the histology report.

Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping.

Fine-needle cytology of cutaneous juvenile xanthogranuloma and langerhans cell histiocytosis.

From open-type atrophic gastritis to gastritis staging.

Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma.

Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells.

Role of miRNA in distinguishing primary brain tumors from secondary tumors metastatic to the brain.

Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling.

Anterior gradient 2 overexpression in lung adenocarcinoma.

HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response.

Epithelial-mesenchymal transition in malignant mesothelioma.

Long-term follow-up of Barrett's epithelium: medical versus antireflux surgical therapy.

Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.

Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas.

miRNAs in precancerous lesions of the gastrointestinal tract.

Clinical guidelines: Secondary prevention of gastric cancer.

Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer.

Congenital pulmonary airway malformation (CPAM) [congenital cystic adenomatoid malformation] associated with tracheoesophageal fistula and agensesis of the corpus callosum.

microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6.

"Double trouble" or an amplification of the triploidy phenotype?

Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma.

[Therapy for non-muscle invasive bladder cancer: HP-NAP].

Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy.

MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome.

Early HER2 dysregulation in gastric and oesophageal carcinogenesis.

Thyroid-like follicular carcinoma of the kidney: report of two cases with detailed immunohistochemical profile and literature review.

Malignant perivascular epithelioid cell tumor of the esophagus.

The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies.

Re: Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

A 14-year-old girl with multiple tumors.

MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options.

PDCD4 expression in thyroid neoplasia.

Survivin expression impacts prognostically on NSCLC but not SCLC.

PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis.

The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples.

Detection of microRNAs in archival cytology urine smears.

The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation.

MicroRNAs and targeted therapy: small molecules of unlimited potentials.

Pathology - grading and staging of GEP-NETs.

The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation.

The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis.

MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia.

DNA qualification workflow for next generation sequencing of histopathological samples.

Advanced precancerous lesions within the GI tract: the molecular background.

MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis.

Pancreatic mucinous cystic tumor in Turner syndrome: How a tumor bends to a genetic disease.

Anti-angiogenic drugs and biomarkers in non-small-cell lung cancer: a 'hard days night'.

B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice.

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.

Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel.

High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers.

A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.

LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer.

Next-generation histopathologic diagnosis: a lesson from a hepatic carcinosarcoma.

Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.

Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract.

Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.

Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation.

microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers.

Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1.

Secondary prevention of epidemic gastric cancer in the model of Helicobacter pylori-associated gastritis.

MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer.

Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma.

High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas.

Evaluation of cell-free DNA as a biomarker for pancreatic malignancies.

Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.

Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression.

Reporting tumor molecular heterogeneity in histopathological diagnosis.

Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis.

The PDCD4/miR-21 pathway in medullary thyroid carcinoma.

Cytokine BAFF released by Helicobacter pylori-infected macrophages triggers the Th17 response in human chronic gastritis.

Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components.

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.

Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study.

Individual risk stratification of gastric cancer: evolving concepts and their impact on clinical practice.

Profiling of expression of human papillomavirus-related cancer miRNAs in penile squamous cell carcinomas.

MicroRNAs as Tools and Effectors for Patient Treatment in Gastrointestinal Carcinogenesis.

Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells.

Genetic features of metachronous esophageal cancer developed in Hodgkin's lymphoma or breast cancer long-term survivors: an exploratory study.

HER2 status in gastroesophageal cancer: a tissue microarray study of 1040 cases.

Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma.

Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer.

Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett's esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population.

A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.

Next-generation sequencing for genetic testing of familial colorectal cancer syndromes.

MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7.

miR-15b/16-2 deletion promotes B-cell malignancies.

From Barrett metaplasia to esophageal adenocarcinoma: the molecular background.

Autoimmune gastritis: Pathologist's viewpoint.

microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers.

Heterogeneous Her2/Neu expression in gastric and gastroesophageal cancer.

Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis.

Young investigator challenge: MicroRNA-21/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology.

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial.

Early signet ring cell carcinoma arising from colonic adenoma: the molecular profiling supports the adenoma-carcinoma sequence.

Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma.

A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with Afatinib.

Different prognostic roles of tumor suppressor gene BAP1 in cancer: A systematic review with meta-analysis.

Peptic Ulcer Disease and Helicobacter pylori Infection in Different Siberian Ethnicities.

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial.

Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis.

Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis.

HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice.

Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers.

Extraskeletal Myxoid Chondrosarcoma of the Foot Clinically Mimicking Plantar Fibromatosis.

Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.

MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma.

Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker.

Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy.

The molecular landscape of colitis-associated carcinogenesis.

Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53.

Insulin promotes HER2 signaling activation during Barrett's Esophagus carcinogenesis.

Team work and cytopathology molecular diagnosis of solid pancreatic lesions.

Whole-genome landscape of pancreatic neuroendocrine tumours.

Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial.

Clear cell colorectal carcinoma: Time to clarify diagnosis.

Fhit down-regulation is an early event in pancreatic carcinogenesis.

Early miR-223 Upregulation in Gastroesophageal Carcinogenesis.

Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis.

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.

Selective targeting of point-mutated KRAS through artificial microRNAs.

PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions.

Gastric Cancer as Preventable Disease.

Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis.

Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver.

Adenosquamous gallbladder carcinoma: Multigene hotspot mutational profiling reveals a monoclonal origin of the two components.

BRAF p.V600E-specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling.

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.

miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma.

Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy.

Characterisation of the immune-related transcriptome in resected biliary tract cancers.

Immunonutrition before esophagectomy: Impact on immune surveillance mechanisms.

Affects the Antigen Presentation Activity of Macrophages Modulating the Expression of the Immune Receptor CD300E through miR-4270.

MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma.

PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways.

Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa.

Circulating miRNAs expression profiling in drug-resistant epilepsy: Up-regulation of miR-301a-3p in a case of sudden unexpected death.

Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research.

Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers.

Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.

KRAS induces lung tumorigenesis through microRNAs modulation.

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.

Onycholemmal carcinoma: A case report with its molecular profiling.

Molecular Diagnostics in Pathology: Time for a Next-Generation Pathologist?

Loss of miR-204 expression is a key event in melanoma.

Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.

Long-Standing Ulcerative Colitis May Trigger a Multilineage Cancerization Field.

Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin.

Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model.

Circulating miRNAs expression profiling in drug-resistant epilepsy: Up-regulation of miR-301a-3p in a case of sudden unexpected death.

MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions.

Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.

Effects of immune suppression for transplantation on inflammatory colorectal cancer progression.

Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions.

Low-grade neuroepithelial tumor: Unusual presentation in an adult without history of seizures.

Correction: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression.

RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients.

Another Chapter of the : Is Primary Tumor Location a Prognostic Feature in Mutant Metastatic Colorectal Cancer?

Precision medicine in cholangiocarcinoma.

Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.

ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance.

Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases.

The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia.

Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.

Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4.

Clear cell dysplasia in a sessile serrated adenoma.

The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ.

Adenosquamous carcinoma of the papilla of Vater: A phenotypic heterogeneity characterized by a common molecular landscape.

Human papillomavirus infection is not involved in esophageal verrucous carcinoma.

miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis.

Knockout of both miR-15/16 loci induces acute myeloid leukemia.

LONG-NONCODING RNAs in gastroesophageal cancers.

Colonic Ewing Sarcoma/PNET associated with liver metastases: A systematic review and case report.

Identification of long intergenic non-coding RNAs (lincRNAs) deregulated in gastrointestinal stromal tumors (GISTs).

Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155).

MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma.

Molecular characterization of "sessile serrated" adenoma to carcinoma transition in six early colorectal cancers.

Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity.

Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETs.

Ramucirumab: the long and winding road toward being an option for mCRC treatment.

miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial.

Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment.

A Case of Carcinosarcoma of the Gastroesophageal Junction With Neuroendocrine and Chondroid Differentiation.

Class 1, 2, and 3 -Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization.

Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens.

Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells.

Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases.

A validated prognostic classifier for BRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study.

Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes.

Thyroid-like follicular carcinoma of the kidney: The mutational profiling reveals a BRAF wild type status.

Tumor mutation burden: from comprehensive mutational screening to the clinic.

Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients' Prognosis.

CK7 and consensus molecular subtypes as major prognosticators in BRAF mutated metastatic colorectal cancer.

Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases.

Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.

CD80 expression promotes immune surveillance in Barrett's metaplasia.